231 related articles for article (PubMed ID: 16137723)
1. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity.
Singh ME; McGregor IS; Mallet PE
Neuropharmacology; 2005 Dec; 49(8):1189-200. PubMed ID: 16137723
[TBL] [Abstract][Full Text] [Related]
2. Perinatal exposure to delta(9)-tetrahydrocannabinol alters heroin-induced place conditioning and fos-immunoreactivity.
Singh ME; McGregor IS; Mallet PE
Neuropsychopharmacology; 2006 Jan; 31(1):58-69. PubMed ID: 15920503
[TBL] [Abstract][Full Text] [Related]
3. Cocaine pre-exposure enhances CRF-induced expression of c-fos mRNA in the central nucleus of the amygdala: an effect that parallels the effects of cocaine pre-exposure on CRF-induced locomotor activity.
Erb S; Funk D; Lê AD
Neurosci Lett; 2005 Aug; 383(3):209-14. PubMed ID: 15955413
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with Delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats.
Kolb B; Gorny G; Limebeer CL; Parker LA
Synapse; 2006 Nov; 60(6):429-36. PubMed ID: 16881072
[TBL] [Abstract][Full Text] [Related]
5. Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission.
Cadoni C; Valentini V; Di Chiara G
J Neurochem; 2008 Aug; 106(4):1586-93. PubMed ID: 18513369
[TBL] [Abstract][Full Text] [Related]
6. Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716.
Singh ME; Verty AN; Price I; McGregor IS; Mallet PE
Neuropharmacology; 2004 Dec; 47(8):1157-69. PubMed ID: 15567425
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic nicotine exposure on Δ
Miladinovic T; Manwell LA; Raaphorst E; Malecki SL; Rana SA; Mallet PE
Pharmacol Biochem Behav; 2020 Jul; 194():172931. PubMed ID: 32353393
[TBL] [Abstract][Full Text] [Related]
8. Morphine and methadone pre-exposures differently modify brain regional Fos protein expression and locomotor activity responses to morphine challenge in the rat.
Taracha E; Chrapusta SJ; Lehner M; Skórzewska A; Maciejak P; Szyndler J; Płaźnik A
Drug Alcohol Depend; 2008 Sep; 97(1-2):21-32. PubMed ID: 18485622
[TBL] [Abstract][Full Text] [Related]
9. Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression.
Boucher AA; Hunt GE; Karl T; Micheau J; McGregor IS; Arnold JC
Neuroscience; 2007 Nov; 149(4):861-70. PubMed ID: 17905522
[TBL] [Abstract][Full Text] [Related]
10. Acute and sensitized response to 3,4-methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression.
Colussi-Mas J; Schenk S
Eur J Neurosci; 2008 Nov; 28(9):1895-910. PubMed ID: 18973603
[TBL] [Abstract][Full Text] [Related]
11. Prenatal cannabis exposure increases heroin seeking with allostatic changes in limbic enkephalin systems in adulthood.
Spano MS; Ellgren M; Wang X; Hurd YL
Biol Psychiatry; 2007 Feb; 61(4):554-63. PubMed ID: 16876136
[TBL] [Abstract][Full Text] [Related]
12. Dissection of peripheral and central endogenous opioid modulation of systemic interleukin-1beta responses using c-fos expression in the rat brain.
Buller KM; Hamlin AS; Osborne PB
Neuropharmacology; 2005 Aug; 49(2):230-42. PubMed ID: 15993445
[TBL] [Abstract][Full Text] [Related]
13. Metabolic mapping of the time-dependent effects of delta 9-tetrahydrocannabinol administration in the rat.
Whitlow CT; Freedland CS; Porrino LJ
Psychopharmacology (Berl); 2002 May; 161(2):129-36. PubMed ID: 11981592
[TBL] [Abstract][Full Text] [Related]
14. Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine.
Cadoni C; Pisanu A; Solinas M; Acquas E; Di Chiara G
Psychopharmacology (Berl); 2001 Nov; 158(3):259-66. PubMed ID: 11713615
[TBL] [Abstract][Full Text] [Related]
15. Regional specificity of ethanol and NMDA action in brain revealed with FOS-like immunohistochemistry and differential routes of drug administration.
Knapp DJ; Braun CJ; Duncan GE; Qian Y; Fernandes A; Crews FT; Breese GR
Alcohol Clin Exp Res; 2001 Nov; 25(11):1662-72. PubMed ID: 11707641
[TBL] [Abstract][Full Text] [Related]
16. Dose and behavioral context dependent inhibition of movement and basal ganglia neural activity by Delta-9-tetrahydrocannabinol during spontaneous and treadmill locomotion tasks in rats.
Shi LH; Luo F; Woodward DJ; Chang JY
Synapse; 2005 Jan; 55(1):1-16. PubMed ID: 15499609
[TBL] [Abstract][Full Text] [Related]
17. The behavioral phenotype of pituitary adenylate-cyclase activating polypeptide-deficient mice in anxiety and depression tests is accompanied by blunted c-Fos expression in the bed nucleus of the stria terminalis, central projecting Edinger-Westphal nucleus, ventral lateral septum, and dorsal raphe nucleus.
Gaszner B; Kormos V; Kozicz T; Hashimoto H; Reglodi D; Helyes Z
Neuroscience; 2012 Jan; 202():283-99. PubMed ID: 22178610
[TBL] [Abstract][Full Text] [Related]
18. Buspirone induced acute and chronic changes of neural activation in the periaqueductal gray of rats.
Lim LW; Temel Y; Sesia T; Vlamings R; Visser-Vandewalle V; Steinbusch HW; Blokland A
Neuroscience; 2008 Jul; 155(1):164-73. PubMed ID: 18588948
[TBL] [Abstract][Full Text] [Related]
19. Widespread expression of Fos protein induced by acute haloperidol administration in the rat brain.
Suzuki M; Sun YJ; Murata M; Kurachi M
Psychiatry Clin Neurosci; 1998 Jun; 52(3):353-9. PubMed ID: 9681590
[TBL] [Abstract][Full Text] [Related]
20. Further evidence that the central nucleus of the amygdala is associated with the ethanol-induced locomotor response.
Demarest K; Hitzemann B; Mahjubi E; McCaughran J; Hitzemann R
Alcohol Clin Exp Res; 1998 Oct; 22(7):1531-7. PubMed ID: 9802539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
